Order Article Reprints

Rodriguez Torres S, Gresseau L, Benhamida M, Fernandez-Marrero Y, Annabi B. Epigallocatechin-3-Gallate Prevents the Acquisition of a Cancer Stem Cell Phenotype in Ovarian Cancer Tumorspheres through the Inhibition of Src/JAK/STAT3 Signaling. Biomedicines. 2023; 11(4):1000. https://doi.org/10.3390/biomedicines11041000

Rodriguez Torres, Sahily, Loraine Gresseau, Meriem Benhamida, Yuniel Fernandez-Marrero, and Borhane Annabi. 2023. "Epigallocatechin-3-Gallate Prevents the Acquisition of a Cancer Stem Cell Phenotype in Ovarian Cancer Tumorspheres through the Inhibition of Src/JAK/STAT3 Signaling" Biomedicines 11, no. 4: 1000. https://doi.org/10.3390/biomedicines11041000

Rodriguez Torres, S., Gresseau, L., Benhamida, M., Fernandez-Marrero, Y., & Annabi, B. (2023). Epigallocatechin-3-Gallate Prevents the Acquisition of a Cancer Stem Cell Phenotype in Ovarian Cancer Tumorspheres through the Inhibition of Src/JAK/STAT3 Signaling. Biomedicines, 11(4), 1000. https://doi.org/10.3390/biomedicines11041000